DIPP-project

DIPP (Diabetes Prediction and Prevention Project) was launched in 1994 in Finland. In the study, general population newborns are screened for increased genetic risk for type 1 diabetes in the University Hospitals of Turku, Tampere and Oulu.

Follow-up study in which they are seen at 3-month intervals for 2 years and at 6-month intervals thereafter.

Children with increased risk are recruited to a follow-up study in which they are seen at 3-month intervals for 2 years and at 6-month intervals thereafter. A blood sample is drawn for analysis of diabetes-associated autoantibodies at every visit. A glucose tolerance test is performed to children with antibodies. If you live far from our research units it is also possible to participate in a long distance protocol study. With this the person participating donates a sample at a laboratory best fitting to his/her needs and all matters related to the research are done over a telephone. Ask more about this possibility from your own research unit.

Antibody positive children also have a possibility to participate in a trial which tests efficacy of nasally administered insulin in type 1 diabetes prevention.

To date, over 8500 children carrying increased genetic risk for type 1 diabetes have participated in the study. Over 110 of them have progressed to clinical diabetes.